病例来源检验时间往期推文参考文献:[1] 张东矗等. 正常孕龄妇女月经周期血清 CA125、CA15-3 和 CA19-9 的变化 [J]. 放射免疫学杂志,201225 (6):690. [2] Claudio Galli et al. CA 19-9: Handle with care. Clin Chem Lab Med 2013; 51(7): 1369–1383.[3] Luo, G. et al. Optimize CA19-9 in detecting pancreatic cancer by Lewis and secretor genotyping. Pancreatology 16, 1057–1062 (2016).[4] Guo, M. et al. Distribution of Lewis and secretor polymorphisms and corresponding CA19-9 antigen expression in a Chinese population. FEBS Open Bio. 7, 1660–1671 (2017).[5] Abe, T. et al. Gene variants that affect levels of circulating tumor markers increase identification of patients with pancreatic cancer. Clin. Gastroenterol. Hepatol. 18, 1161–1169 (2020).[5] B.J. Kim et al. How do we interpret an elevated carbohydrate antigen 19-9 level in asymptomatic subjects? Digestive and Liver Disease. 4, 1364–369 (2009).[5] M. Ventrucci et al. ersistent elevation of serum CA 19-9 with no evidence of malignant disease. Digestive and Liver Disease 41 (2009) 357–363.[7] Sunyoung Kim et al. Carbohydrate antigen 19-9 elevation without evidence of malignant or pancreatobiliary diseases. Scientific Reports (2020) 10:8820.[8] Sang Pyo Lee et al. Usefulness of Carbohydrate Antigen 9-9 Test in Healthy People and ecessity of Medical Follow-up in ndividuals with Elevated Carbohydrate ntigen 19-9 Level. Korean J Fam Med 2019; 0:314-322[9] Hye-Ryoun Kim et al. Increased CA 19-9 level in patients without malignant disease. Clin Chem Lab Med 2009;47(6):750–754.[10] Xiaoxi Wang et al. An extremely increased CA19-9 level due to common bile duct stone: a case report. AME Med J 2017;2:18.[11] Henry F. Sears. Specific Antigen in Serum of Patients with Colon Carcinoma. Science, 212;1981.(▲▼ 上下滑动查看全部内容)